Oral contraceptives and the risk of gallbladder disease: a meta-analysis
about
Oral contraceptives and the risk of gallbladder disease: a comparative safety studyEpidemiology of gallbladder disease: cholelithiasis and cancerInsulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal womenUse of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006.Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.Pediatric obesity and gallstone disease.A high cholecystectomy rate in a cohort of Mexican American women who are postpartum at the time of oral contraceptive pill initiationInhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female miceGallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort studyRisk factors for symptomatic gall bladder disease.Sex and ethnic/racial-specific risk factors for gallbladder disease.Age at Menarche and Gallstone Disease in Middle-Aged Women.Prevalence of gallstone disease in a Swedish population sample. Relations to occupation, childbirth, health status, life style, medications, and blood lipids.
P2860
Q24595632-AD97162A-66D0-4275-B2E3-338DDD550EEFQ24629433-1D7767F0-661D-4227-9272-02629938D4B3Q30473662-DDC57DB7-2F6E-4D0B-A591-55A7880E1BAAQ34930051-FADDE091-526F-49C5-AE04-8BA95AC1D261Q35994356-CB7DEAC2-EF37-44A5-9C3B-A4C09E160A36Q36107488-E2CDCB14-ECE4-4298-BFDC-42C6F3B4B00DQ36183733-33814C35-0AD7-47E3-8CFB-3EA031872893Q36357292-7433B9AD-034F-4C1A-842B-FBE45766E5E1Q36425257-2627BF31-AED5-44D6-9A43-4F294001E0FFQ36429659-DA8C7232-31D5-4C06-BF8E-9BD58C12871CQ36818049-6D942204-67B8-451F-B177-BFCF47FE085AQ43214177-0843EE26-0078-4EDF-AB61-2EC5458AA9E1Q46745482-3CF5EBBF-E127-4139-A428-20F1D7D65D4FQ50166085-FE585546-0C63-4DC0-8B64-F43D721CCAF6Q50850721-28151366-E248-4B75-9C1E-13E15AE69970
P2860
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@ast
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@en
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@nl
type
label
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@ast
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@en
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@nl
prefLabel
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@ast
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@en
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@nl
P2860
P356
P1476
Oral contraceptives and the risk of gallbladder disease: a meta-analysis
@en
P2093
P2860
P304
P356
10.2105/AJPH.83.8.1113
P407
P577
1993-08-01T00:00:00Z